Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Primary Mediastinal B Cell Lymphoma Treated with CHOP-Like Chemotherapy with or without Rituximab: 5-Year Results of the Mabthera International Trial Group (MInT) Study

Mathias Witzens-Harig, MD, Anthony D Ho, MD, Evelyn Kuhnt, Marek Trneny, MD, Michael Rieger, MD, Anders Österborg, MD, PhD, Ruth Pettengell, Robert Stevens, MD, Devinder S Gill, MB ChB, MRCP (UK), FRCPath (Lond), Jan Walewski, Markus Loeffler, Michael Pfreundschuh, MD

Blood (2012) 120 (21): 1612.

https://doi.org/10.1182/blood.V120.21.1612.1612

Published: 2012

Journal Articles

Dishevelled Proteins of Wnt Signaling Pathways Are Highly Expressed in Chronic Lymphocytic Leukemia

Abdul Salam Khan, Åsa Sandin, Anders Österborg, MD, PhD, Mohammad Hojjat-Farsangi, Håkan Mellstedt, MD, PhD, Ali Moshfegh, PhD

Blood (2012) 120 (21): 4583.

https://doi.org/10.1182/blood.V120.21.4583.4583

Published: 2012

Journal Articles

Monoclonal Antibody Against ROR1 in Chronic Lymphocytic Leukemia Cells Induced Apoptosis Via PI3-Kinase/AKT/CREB Pathway

Amir Hossein Daneshmanesh, MD, PhD, Mohammad Hojjat-Farsangi, PhD, Asa Sandin, PhD, Abdul Salam Khan, Msc, Ali Moshfegh, PhD, Mahmood Jeddi-Tehrani, PhD, Anders Österborg, MD, PhD, Håkan Mellstedt, MD, PhD

Blood (2012) 120 (21): 1769.

https://doi.org/10.1182/blood.V120.21.1769.1769

Published: 2012

Journal Articles

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

Blood (2011) 118 (21): 331.

https://doi.org/10.1182/blood.V118.21.331.331

Published: 2011

Journal Articles

Randomized Phase II Study of BLP25 Liposome Vaccine (L-BLP25) in Patients with Multiple Myeloma

Eva Rossmann, Anders Österborg, Eva Löfvenberg, Aniruddha Choudhury, Ulf Forssmann, Stefanie Senger, Andreas Schröder, Håkan Mellstedt

Blood (2011) 118 (21): 2927.

https://doi.org/10.1182/blood.V118.21.2927.2927

Published: 2011

Journal Articles

Current Practice In Diagnosis and Treatment of Chemotherapy-Induced Anemia In Five European Countries – A Patient Record Study

Yves Beguin, MD, PhD, Matti Aapro, MD, Carsten Bokemeyer, MD, John Glaspy, MD, Michael Hedenus, MD, Timothy James Littlewood, MD, FRCP, Heinz Ludwig, MD, Anders Österborg, MD, Daniell Mitchell, PhD

Blood (2010) 116 (21): 1512.

https://doi.org/10.1182/blood.V116.21.1512.1512

Published: 2010

Journal Articles

Ror1 Targeting Monoclonal Antibodies Induced Apoptosis of Chronic Lymphocytic Leukemia Cells– A Potential Novel Therapeutic Approach

Hodjattallah Rabbani, PhD, Amir Hossein Daneshmanesh, MD, Abdul Salam Khan, MSc, Mohammad Hojjat-Farsangi, PhD, Mahmood Jeddi-Tehrani, PhD, Mohammad Mehdi Akhondi, PhD, Anders Österborg, MD, PhD, Fazel Shokri, PhD, Håakan Mellstedt, MD, PhD

Blood (2010) 116 (21): 916.

https://doi.org/10.1182/blood.V116.21.916.916

Published: 2010

Journal Articles

Final Analysis From the International Trial of Single-Agent Ofatumumab In Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia

Blood (2010) 116 (21): 921.

https://doi.org/10.1182/blood.V116.21.921.921

Published: 2010

Journal Articles

Correlation Between Serum Ofatumumab Concentrations, Baseline Patient Characteristics and Clinical Outcomes in Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia (CLL) Treated with Single-Agent Ofatumumab.

Blood (2009) 114 (22): 3433.

https://doi.org/10.1182/blood.V114.22.3433.3433

Published: 2009

Journal Articles

IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G 2 /M-phase accumulation and apoptosis in multiple myeloma cells

Thomas Strömberg, Simon Ekman, Leonard Girnita, Lina Y. Dimberg, Olle Larsson, Magnus Axelson, Johan Lennartsson, Ulf Hellman, Kristina Carlson, Anders Österborg, Karin Vanderkerken, Kenneth Nilsson, Helena Jernberg-Wiklund

Blood (2006) 107 (2): 669–678.

https://doi.org/10.1182/blood-2005-01-0306

Published: 2006

Includes: Supplemental data

Journal Articles

Expression of Erythropoietin Receptor (EPO-R) and In Vitro Functional Effects of Epoetin in B-Cell Malignancies.

Amir Abdalla, Parviz Kokhaei, Lotta Hansson, Manfred Kubbies, Anton Haselbeck, Eva Mikaelsson, Helena Jernberg-Wiklund, Håkan Mellstedt, Anders Österborg Österborg

Blood (2005) 106 (11): 4278.

https://doi.org/10.1182/blood.V106.11.4278.4278

Published: 2005

Journal Articles

Reconstitution of the T Cell Repertoire Following Treatment with Alemtuzumab in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Mohammad R. Rezvany, Mahmood J. Tehrani, Claes Karlsson, Jeanette Lundin, Hodjattallah Rabbani, Håkan Mellstedt, Anders Österborg

Blood (2005) 106 (11): 2986.

https://doi.org/10.1182/blood.V106.11.2986.2986

Published: 2005

Journal Articles

Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells

Lina Y. Dimberg, Anna I. Dimberg, Karolina Ivarsson, Thomas Strömberg, Anders Österborg, Kenneth Nilsson, Fredrik Öberg, Helena Jernberg Wiklund

Blood (2005) 106 (4): 1346–1354.

https://doi.org/10.1182/blood-2004-04-1322

Published: 2005

Includes: Supplemental data

Journal Articles

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma

Eva Mikaelsson, Amir Hossein Danesh-Manesh, Alfred Lüppert, Mahmood Jeddi-Tehrani, Mohammad-Reza Rezvany, Ramazan Ali Sharifian, Reza Safaie, Azam Roohi, Anders Österborg, Fazel Shokri, Håkan Mellstedt, Hodjattallah Rabbani

Blood (2005) 105 (12): 4828–4835.

https://doi.org/10.1182/blood-2004-10-3941

Published: 2005

Journal Articles

No cardiac toxicity associated with alemtuzumab therapy for mycosis fungoides/Sézary syndrome

Jeanette Lundin, Ben Kennedy, Claire Dearden, Martin J. S. Dyer, Anders Österborg

Blood (2005) 105 (10): 4148–4149.

https://doi.org/10.1182/blood-2004-11-4314

Published: 2005

Journal Articles

Effect of Epoetin beta on Survival, Tumor Progression and Thromboembolic Events in Patients with Lymphoid Malignancies Receiving Chemotherapy: A Meta-Analysis of Controlled Clinical Studies.

Bertrand Coiffier, Marc Boogaerts, Anders Österborg, Hans-Ulrich Burger

Blood (2004) 104 (11): 3149.

https://doi.org/10.1182/blood.V104.11.3149.3149

Published: 2004

Journal Articles

Downregulating the Fibromodulin Gene by Short Interfering RNA Causes B-CLL Cell Death.

Aniruddha Choudhury, Ph.D., Katja Derkow, B.S., Eva Mikaelsson, B.S., Parviz Kokhaei, B.S, Anders Österborg, M.D., Ph.D., Hodjattallah Rabbani, Ph.D., Håkan Mellstedt, M.D., Ph.D.

Blood (2004) 104 (11): 176.

https://doi.org/10.1182/blood.V104.11.176.176

Published: 2004

Journal Articles

Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone

Thomas Strömberg, Anna Dimberg, Anna Hammarberg, Kristina Carlson, Anders Österborg, Kenneth Nilsson, Helena Jernberg-Wiklund

Blood (2004) 103 (8): 3138–3147.

https://doi.org/10.1182/blood-2003-05-1543

Published: 2004

Journal Articles

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

Gunilla Enblad, Hans Hagberg, Martin Erlanson, Jeanette Lundin, Anja Porwit MacDonald, Roland Repp, Johannes Schetelig, Gernot Seipelt, Anders Österborg

Blood (2004) 103 (8): 2920–2924.

https://doi.org/10.1182/blood-2003-10-3389

Published: 2004

Journal Articles

T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma

Lotta Hansson, Hodjattallah Rabbani, Jan Fagerberg, Anders Österborg, Håkan Mellstedt

Blood (2003) 101 (12): 4930–4936.

https://doi.org/10.1182/blood-2002-04-1250

Published: 2003

NARROW

Primary Mediastinal B Cell Lymphoma Treated with CHOP-Like Chemotherapy with or without Rituximab: 5-Year Results of the Mabthera International Trial Group (MInT) Study

Dishevelled Proteins of Wnt Signaling Pathways Are Highly Expressed in Chronic Lymphocytic Leukemia

Monoclonal Antibody Against ROR1 in Chronic Lymphocytic Leukemia Cells Induced Apoptosis Via PI3-Kinase/AKT/CREB Pathway

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

Randomized Phase II Study of BLP25 Liposome Vaccine (L-BLP25) in Patients with Multiple Myeloma

Current Practice In Diagnosis and Treatment of Chemotherapy-Induced Anemia In Five European Countries – A Patient Record Study

Ror1 Targeting Monoclonal Antibodies Induced Apoptosis of Chronic Lymphocytic Leukemia Cells– A Potential Novel Therapeutic Approach

Final Analysis From the International Trial of Single-Agent Ofatumumab In Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia

Correlation Between Serum Ofatumumab Concentrations, Baseline Patient Characteristics and Clinical Outcomes in Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia (CLL) Treated with Single-Agent Ofatumumab.

IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G 2 /M-phase accumulation and apoptosis in multiple myeloma cells

Expression of Erythropoietin Receptor (EPO-R) and In Vitro Functional Effects of Epoetin in B-Cell Malignancies.

Reconstitution of the T Cell Repertoire Following Treatment with Alemtuzumab in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma

No cardiac toxicity associated with alemtuzumab therapy for mycosis fungoides/Sézary syndrome

Effect of Epoetin beta on Survival, Tumor Progression and Thromboembolic Events in Patients with Lymphoid Malignancies Receiving Chemotherapy: A Meta-Analysis of Controlled Clinical Studies.

Downregulating the Fibromodulin Gene by Short Interfering RNA Causes B-CLL Cell Death.

Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only